Skip to content
Disclosery

13F-HR filed by ETF MANAGERS GROUP, LLC

ETF MANAGERS GROUP, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-03-23, with 513 holding rows worth $2,133,716,610.

Accession
0001213900-23-022243
Filer
CIK 1645173
Filed
2023-03-23
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 586 entries on the cover page, a total value of $2,133,716,610 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,133,716,610 with VALUE read as dollars as filed, 13F file number 028-17572. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CORMEDIX INC COM21900C308Stock10,292$43,432dollars as filed
CHIMERIX INC COM16934W106Stock21,951$40,829dollars as filed
INVIVYD INC00534A102COMMON STOCK27,171$40,757dollars as filed
RACKSPACE TECHNOLOGY INC750102105COM13,702$40,421dollars as filed
VAXART INC NEW92243A200COM32,722$31,443dollars as filed
PARATEK PHARMACEUTICALS INC699374302Equity13,849$25,898dollars as filed
CEL-SCI CORP150837607COM PAR NEW10,812$25,408dollars as filed
VBI VACCINES INC91822J103COM NEW64,387$25,182dollars as filed
AGRIFY CORP REVERSE SPLIT EFF: 07/05/2300853E206COMMON STOCK55,404$18,450dollars as filed
Atossa Therapeutics Inc04962H506Common Stock31,569$16,684dollars as filed
EDGIO INC53261M104COM14,070$15,899dollars as filed
ASSEMBLY BIOSCIENCES INC045396108COM12,161$15,809dollars as filed
HOOKIPA PHARMA INC43906K100COM13,642$11,050dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001213900-23-022243this filing2023-03-23acceptance time not in the bulk data set